Claudia Ordonez

Insider Reports History

Entity
Individual
Location
C/O Keros Therapeutics, Inc., 99 Hayden Avenue, Suite 120, Building E, Lexington, MA
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Claudia Ordonez:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Keros Therapeutics, Inc. Chief Medical Officer Employee Stock Option (right to buy) 98.2K Jun 11, 2021 Direct
Keros Therapeutics, Inc. Chief Medical Officer Common Stock 0 $45.29 Jun 11, 2021 Direct

Insider Reports Filed by Claudia Ordonez

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KROS Keros Therapeutics, Inc. Jun 11, 2021 4 -$50.5K 4 Jun 15, 2021 Chief Medical Officer
KROS Keros Therapeutics, Inc. May 11, 2021 3 -$49.7K 4 May 13, 2021 Chief Medical Officer